• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

International Biotechnology Trust PLC (IBT)

ORD 25P
Sell: 1,110.00p|Buy: 1,115.00p|Change: 0 (0%)

Open 

1,110.00p

Previous close 

1,110.00p

Trade high 

1,122.98p

Estimated NAV 

1,171.31 

Year high 

1,235.00p

Year low 

668.625p

Premium / Discount 

-5.23%

Market capitalisation 

£351.35 mn

Volume 

64,880

Dividend yield 

2.59%

Ongoing charge 

1.2698%

ISIN 

GB0004559349

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Before investing please read:

Key Information Document (KID/KIID)/Product Summary

Share price

Dividends

PreviousLatest
Record date30/12/202524/07/2026
Ex-dividend date29/12/202523/07/2026
Payment date23/01/202621/08/2026
Amount15.64p15.67p

Net asset value (NAV)

Estimated NAV1,171.31
Latest actual NAV1,188.10
Latest actual NAV date08 September 2026
12m average premium/discount-7.63%

Top 10 holdings

Holdings 31/07/2026% of assets
Insmed Inc5.82
Vera Therapeutics Inc Class A5.22
Gilead Sciences Inc4.70
United States Treasury Bills 0%4.64
Travere Therapeutics Inc Ordinary Shares4.38
Alnylam Pharmaceuticals Inc4.37
Madrigal Pharmaceuticals Inc3.66
Vertex Pharmaceuticals Inc3.63
Supernus Pharmaceuticals Inc3.39
Amgen Inc3.35

Performance 31/08/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Fund-
Category-
More...

Investment objective

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

Morningstar ratingTM

Morningstar sustainability ratingTM

  Morningstar report document

News

Recent trades

DateTimePriceQuantityValue (£)
10/09/202604:38:0211103944,373.40
10/09/202604:35:1911105,00055,500.00
10/09/202604:29:581112.51,48616,531.75
10/09/202604:29:5811105005,550.00
10/09/202604:29:5811108008,880.00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.